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Induction of IL-i during hemodialysis: Transmembrane passage of
intact endotoxins (LPS). Circulating monocytes of patients undergoing
chronic hemodialysis are triggered to produce interleukin- I (IL-I) in
vivo. Intradialytic induction of IL-I is associated with complement
activation in patients dialyzed with first-use cellulose membranes.
Chronic stimulation of IL-I production occurs because of an yet
unidentified mechanism in patients dialyzed with high permeability
membranes. The present study demonstrates that intact bacterial lipo-
polysaccharide (LPS) molecules may cross cuprophan, AN69 and
polysulfone membranes under in vitro conditions simulating in vivo
hemodialysis. The experiments used purified LPS from Neisseria
meningitidis and LPS from Pseudomonas festosteroni, a bacterial strain
grown out from a clinically used dialysate. LPS were purified to
homogeneity and radiolabeled. Transmembrane passage of 3H-labeled
LPS was observed within the first five minutes of dialysis. A total of 0.1
to 1% of 3H-labeled LPS were recovered in the dialysate compartment
after one hour of dialysis. High amounts of LPS, representing 40 to 70%
of the amount originally present in the dialysate, were absorbed onto
high permeability membranes. Low amounts of LPS were absorbed
onto cuprophan membranes. The amount of LPS absorbed decreased
with the concentration of LPS in the dialysate. LPS recovered from the
blood compartment exhibited the same molecular weight as that used to
contaminate the dialysate. Biochemically detectable transmembrane
passage of LPS was not associated with that of material detectable
using the limulus amebocyte lysate (LAL) assay. An IL-I-inducing
activity was, however, detected in the blood compartment upon dialysis
with high permeability membranes, as previously found by others with
cuprophan membranes. These results provide a basis for the chronic
induction of IL-I production in patients dialyzed with high permeability
membranes and for an enhancing mechanism of complement-dependent
induction of IL-I in patient dialyzed with cuprophan membranes. Our
observations emphasize the importance of obtaining LPS-free dialy-
sates to improve the biocompatibitity of hemodialysis.
Circulating monocytes of patients undergoing chronic hemo-
dialysis are triggered to produce interleukin-1 (IL-i) in vivo [1].
A number of biological activities mediated by IL-I could
account for acute phase responses and some of the adverse
effects associated with hemodialysis [2, 3]. A transient intradi-
alytic increase in IL-i production occurs in patients undergoing
dialysis with first-use cuprophan membranes, as assessed by
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the presence of cell associated IL- 1 activity and immunoreac-
tive IL-la and IL-l/3 in lysates of circulating monocytes.
Induction of IL-i production and subsequent accumulation of
intracellular IL-l is associated with complement activation [1]
that is a constant feature in patients dialyzed with first use
cellulose membranes [4—6]. A different pattern of IL-i produc-
tion was observed in patients dialyzed with high permeability
membranes. High levels of cell-associated IL-i were found in
pre-dialysis samples of some of these patients, whereas no
intradialytic increase occurred during the dialysis session.
These observations suggested that a complement-independent
mechanism could chronically induce IL-I in circulating mono-
cytes from patients dialyzed with high permeability mem-
branes. We therefore tested the hypothesis of transmembrane
passage of bacterial lipopolysaccharide (LPS) from contam-
inated dialysates into the blood compartment. Previous reports
have indicated that an IL-I inducing activity was found in the
blood compartment during in vitro dialysis with cellulose mem-
branes and endotoxin-contaminated dialysate [7, 8]. Clinical
studies have, however, failed to demonstrate the passage of
endotoxin into the blood compartment by using the limulus
amebocyte lysate assay (LAL) for the detection of LPS [8—111.
The present study provides the first demonstration that intact
LPS from clinically-relevant bacterial strains cross AN69,
polysulfone and cuprophan membranes during in vitro dialysis.
LPS recovered from the blood compartment is capable of
inducing IL-i production in normal human peripheral blood
monocytes.
Methods
In vitro dialysis circuits
Figure 1 depicts the general scheme of closed-loop dialysis
circuits that were used. Dialyzers were either standard capillary
hemodialyzers for clinical use or miniaturized custom-made
capillary dialyzers. Standard dialyzers for clinical use were the
cuprophan NT1 108 dialyzer from Sorin Biomedica (Tomb,
Italy), the AN69 polyacrylanitrile Filtral 12 dialyzer from Hos-
pal SA (Meyzieu, France), and the polysulfone Hemofiow F60
dialyzer from Fresenius (Wendel, FRG) with membrane surface
areas of 1.06 m2, 1.17 m2 and 1.25 m2, respectively. Blood lines
were hemodialysis line sets (Tygon S 50 HL; Prolabo, Norton,
USA). Lines from the dialysate compartment were silicone
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Fig. 1. Flow diagram of in vitro closed dialysis circuit s. Dialyzers were
eitherstandard hemodialyzers for clinical use or miniaturized dialyzers.
The open triangles depict peristaltic pumps. a: back filtration and
compensation of back filtration with saline.
lines from Hospal SA. The system was assembled under sterile
conditions. The circuits were extensively rinsed with pyrogen-
free saline. Dialysate flow rates were 150 to 500 mi/mm. The
dialysate compartment contained either pyrogen-free saline or
sterile bicarbonate solution pH 7.4 containing 60 mM Na, 35
mM HC03 and 25 mi Cl. The blood compartment contained
pyrogen-free (that is, LAL-negative) saline. The flow rates were
100 mI/mm in vitro dialysis was performed for 30 to 120 minutes
at 22°C or 37°C. Back filtration was used in the study of
transmembrane passage of IL-I inducing activity. Samples
were taken from the dialysate and blood compartments at
various time points of circulation. Experiments were conducted
in a similar fashion with miniaturized capillary dialyzers. Sur-
face areas of dialysis membranes were 527 cm2 (cuprophan),
512 cm2 (AN69) and 273 cm2 (polysulfone). Dialysate flow rate
was 20 mI/mm.
Bacterial lipopolysaccharides
Lipopolysaccharides were phenol-extracted from two strains
of gram negative bacteria, Neisseria meningitidis (Nm) and
Pseudomonas testosieroni (Pt), purified by further extraction
using PCP [12]. Purified LPS from E. coli 0111 B4 was pur-
chased from Sigma Chemical Corp. (St Louis, Missouri, USA).
Purified LPSs were devoid of detectable contaminating DNA
and protein [13]. Figure 2 shows silver-stained SDS-PAGE
analysis of purified LPSs [14]. Nm LPS was present as a single
molecular species of apparent Mr 4600 [14]. Pt LPS consisted of
two major species, one of apparent Mr 2000, the other slightly
over 4600 with a higher content in polysaccharidic repetitive
units. Fatty acids in LPS were released by methanolysis (5%
HCI wtivol) in anhydrous methanol for four hours at 95°C, and
estimated by gas chromatography analysis (GLC) of the methyl
ester derivatives. Samples, with alditol as internal reference,
were hydrolyzed with 0.125 M sulfuric acid for 16 hours at
100°C, followed by neutralization (BaCO3) and concentration.
The sugars were then reduced with sodium borohydride and
peracetylated (0.5 ml Ac20, 2 hr, 100°C). GLC analyses were
performed with a GC 4180 instrument (Erba Science, Massy,
France) equipped with a vitreous silica (WCOT type) capillary
column (0.32 mm x 25 m) coated with a BP 10 bond phase (0.5
Fig. 2. SDS-PAGE electrophoresis of pure/led !ipopolysaccharides.
Lanes 1, 2 and 3 correspond to 10 ng of LPS from E. coli 0111 B4,
Neisseria meningitidis and Pseudomonas lestosteroni, respectively.
Electrophoresis was performed in 15% polyacrylamide slab gels in the
presence of 0.1% SDS [12].
.t thickness). For fatty acids, the program was 200°C to 240°C,
3°C/mm. Alditol acetates were isothermally run at 220°C.
Labeling of lipopolysaccharides
Radiolabeling of Nm LPS and Pt LPS was performed using a
modification of the method described by Watson and Riblet [15]
and Haeffner-Cavaillon et al [16]. LPSs were oxidized in the
presence of Na104 (2 x 10_2 M) for 20 minutes at room
temperature and then reduced in the presence of 25 mCi of
NaB3H4 (specific activity 16 Ci/mM) in 0.05 M borate buffer, pH
9.0 overnight at 4°C. After destruction of excess sodium boro-
hydride, the radioactive material was ultracentrifuged several
times for 45 minutes at 290.000 g until no residual radioactivity
could be detected in the supernatant. The specific activity of
labeled endotoxins was 1,350,000 cpm/g and 4,250,000 cpm/pg
for Nm LPS and Pt LPS, respectively. The labeling procedure
did not alter the IL- 1 inducing activity of NmLPS as assessed
by measuring the production of IL-i activity in monocytes
cultured in the presence of NmLPS that had been treated with
cold NaBH4 (data not shown).
Thin layer chromatography of3H-LPS
For thin layer chromatography (TCL) aluminium backed
precoated silica gel 60 plates (Merck, Darmstadt, RFA) were
used. LPS samples were developed with isobutyric acid, molar
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ammonium hydroxide (5;3) as solvant. The material was then
revealed by charring.
Limulus amebocyte lysate assay (LAL)
The limulus amebocyte lysate assay (LAL) was performed
using the procedure developed by Whittaker MA Bioproducts
(Walkersville, Maryland, USA) and Kabi Vitrum (Stockholm,
Sweden), according to the manufacturers' instructions. Results
were expressed in endotoxin U/mi (EU/ml) relative to an E. coli
0111 B4 LPS standard.
Preparation of peripheral blood monocytes and IL-I assays
Peripheral blood mononuclear cells (PBMC) were separated
from ACD-anticoagulated whole blood of healthy donors by
centrifugation on MSL (milieu de separation des lymphocytes;
Eurobio, Paris, France). Monocytes were identified by staining
with non-specific esterase (NSE) using alphanaphtyl acetate as
substrate [171. Mononuclear cells were enriched in monocytes
by allowing the cells to adhere to 24-well plastic culture dishes
(Falcon, Lincoln Park, New Jersey, USA) in the absence of
serum for 45 minutes at 37°C. Under these conditions, adherent
cells contained more than 85% monocytes. Cell-associated IL- 1
activity was determined following the culture of adherent cells
(0.5 x 106 NSE cells/well), in RPMI 1640 containing 100 lU/mi
penicillin and 100 /.Lg/ml streptomycin in the presence or ab-
sence of IL-i inducer for 24 hours at 37°C. To determine
cell-associated IL-i activity, mononuclear cells were lysed by
three freeze-thaw cycles at —80°C in 0.5 ml RPM! 1640 con-
taining antibiotics [1, 181. After centrifugation of the lysates at
2000 g for 10 minutes at 4°C, IL-i activity was measured in the
supernatants by means of a conventional Con A co-mitogenic
assay using C3H/HeJ thymocytes [19]. The freeze-thawing
procedure yielded reproducible results as previously described
[I]. Results of IL-I measurements were expressed as mean cpm
of [3H] thymidine incorporated in 0.75 x 106 thymocytes in
triplicate cultures. Standard deviations between cpm incorpo-
rated in triplicate thymocyte cultures did not exceed 15%.
Results
Transmembrane passage of IL-I inducing material
In order to investigate whether endotoxin may cross high
permeability membranes and induce IL-I production in the
blood compartment, we used the closed dialysis circuit depicted
in Figure 1, bicarbonate in the dialysate compartment was
contaminated with purified Nm LPS (0.8 gIml; 2,000 EU/mI).
Pyrogen-free saline was circulated in the blood compartment.
The membrane was AN69 and the dialyzer, a Filtral 12 unit for
clinical use. Samples were taken from the dialysate and the
blood compartment at different time points of dialysis. One
hundred s1 of the undiluted sample were added to culture wells
containing 0.5 x l0 adherent mononuclear cells in 0.4 ml RPM!
1640. Cell associated IL-i activity was assessed in cell lysates
after 24 hours of culture. As shown in Figure 3, an early and
transient peak of IL-i inducing activity was detected samples
from the blood compartment obtained after 10 minutes of
dialysis. A second peak of IL-i-inducing activity was detected
following artificially-induced back filtration in the circuit. The
limulus assay did not detect positive material in blood loop
samples at any time point throughout the dialysis period. No
Time, minutes
Fig. 3. Transmembrane passage of IL-I inducing activity through high
permeability dialysis membranes. Closed dialysis circuit with a Filtral
12 dialyzer and an AN69 membrane. Bicarbonate in the dialysate
compartment was contaminated with Nm LPS (0.8 j.gim1). Pyrogen-
free saline was circulated in the blood compartment. The figure depicts
cell-associated IL-i activity that was induced in cultures of normal
human monocytes performed in the presence of saline or bicarbonate
drawn from the blood compartment (•) and the dialysate compartment
(0). Cultures of monocytes and IL-I assays were performed as de-
scribed in Methods. Closed triangles depict IL-i activity induced by
saline drawn from the blood compartment in a sham experiment with
uncontaminated dialysate. The arrow depicts the time at which back
filtration was started. The figure shows a representative experiment of
two that were performed.
IL-i inducing activity was found in samples drawn from the
blood compartment in a sham experiment with uncontaminated
dialysate.
Transmembrane passage of LPS through dialysis membranes
To demonstrate the ability of intact LPS to cross high
permeability membranes, the dialysate compartment of a closed
circuit was contaminated with radiolabeled purified Nm LPS or
with radiolabeled LPS from the clinically relevant bacterium P.
testosteroni. Pt LPS was purified from bacteria grown on a
trypticase-soja medium out of a clinically used dialysate. Puri-
fied Nm LPS and Pt LPS were not contaminated with DNA nor
protein. Nm LPS migrated as a single spot upon thin layer
chromatography (Fig. 4). All radioactivity was associated with
LPS (Fig. 4). Purified Pt LPS migrated as two molecular species
of apparent Mr 2,000 and above 4,000 Da (lane I of Fig. 5). The
two components of Pt LPS were separated using thin layer
chromatography (Fig. 5) and characterized as exclusively being
LPS. The material was eluted and the content of altidolacetate
and methylester derivatives was analyzed by gas chromatogra-
phy. Both f3-hydroxy-myristic acid and heptose residue, char-
acteristic of LPS, were present in each component. Figure 6
shows the kinetics of transmembrane passage of [3H]-Nm LPS
(0.1 g/ml of dialysate) through AN69. A rapid increase in
radioactivity in the blood compartment within the first five
,
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Fig. 5. SDS-PAGE electrophoresis of pur(fied Pt LPS. Lanes 1 and 11:
50 ng; Lanes 2 and 10: 20 ng; Lane 3: 10 ng. The material recovered in
the dialysate of a closed circuit dialysis with polysulfone, cuprophan
and AN69 membranes is shown in lanes 4, 6 and 8, respectively. The
material recovered from the blood compartment following dialysis with
polysulfone, cuprophan and AN69 membranes are shown in lanes 5, 7
and 9. SDS-PAGE analysis was performed as depicted in Figure 2.
Insert: thin layer chromatography of Pt LPS used for transmembrane
passage experiments. Lane I of insert: native LPS. Lanes 2 and 3 of
insert: high and low molecular species separated by preparative thin
layer chromatography.
minutes of dialysis to reach a plateau thereafter. The total
amount of labeled material detected in the blood compartment
represented 0.1 to 1% of that which was originally added to the
dialysate compartment, depending on the amount of LPS that
was used to contaminate the dialysate. Twenty-five to 30% of
the latter amount were recovered from the dialysate, indicating
that Nm LPS adsorbs onto the AN69 membrane. [3H1-Pt LPS
crossed AN69 membranes with kinetics similar to those of Nm
LPS whether passage of LPS was assessed in a miniaturized
circuit (data not shown) or using a closed circuit and a Filtral 12
dialyzer for clinical use (Fig. 7). Figure 7 also shows the
transmembrane passage of [3H1-Pt LPS through polysulfone
and cuprophan membranes. The experiments were performed
using distilled water in the dialysate and in the blood compart-
ment in order to allow the chemical characterization and
molecular weight determination of LPS species in both com-
partments. SDS-PAGE analysis of the material recovered from
the blood compartment is depicted in Figure 5. Silver-stained
Fig. 6. Kinetics of zransmembrane passage of 13H1 Mm LPS through
the AN69 membrane. Closed miniaturized circuit. The concentration of
[3H] Nm LPS in the dialysate was 1.1 g/ml. Symbols are: (• •)
[3H] Nm LPS in the dialysate compartment; (O----O) [H) Nm LPS in
the blood compartment. The figure shows a representative experiment
out of three that were performed. Each point represents the mean of
triplicate measurements (so between triplicates did not exceed 10% of
the mean).
material of molecular weight similar to that of Pt LPS present in
the contaminated dialysate, was found in the blood compart-
ment of closed circuits with polysulfone (lanes 4 and 5 of Fig.
5), cuprophan (lanes 6 and 7 of Fig. 5) and AN69 (lanes 8 and 9
of Fig. 5) membranes. Experiments not shown demonstrated
that the presence of normal human serum diluted 1:2 in the
blood compartment did not significantly alter the amount nor
the kinetics of transmembrane passage of LPS through AN69
and cuprophan membranes.
Adsorption of LPS onto dialysis membranes
Adsorption of LPS from the dialysate onto dialysis mem-
branes was quantitated in experiments using a closed circuit
and AN69, polysulfone and cuprophan membranes. At time
zero (To) of the experiments, [3H] Nm LPS (0.5 g/ml) was
added to the dialysate. After 60 minutes of dialysis, we assessed
the residual amount of radioactivity present in the dialysate
compartment and the amount of radioactivity that could be
eluted form the membrane following a one night wash of the
circuit with pyrogen-free distilled water containing 10% SDS.
As shown in Table 1, 85%, 95% and 61% of the loaded
radioactivity were found in the dialysate compartment after 60
minutes of dialysis with AN69, cuprophan and polysulfone
membranes respectively. SDS-eluted radioactivity represented
3.5%, 1.9% and 8.6%, respectively, of the radioactive input.
.... front 'V
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3H-LPS,cpm x 10-6
FIg. 4. Thin layer chromatography of 3H-radiolabeled pur(fied LPS
from Nm. The material that had migrated was revealed either using
sulfuric acid (A) or by counting radioactivity in adjacent slices of the
silica gel (B).
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Table 1. Retention of 3H-LPS on dialysis membran
dialysisa
es during in vitro
[3H] LPS cpm x 10-3b
Dialysate at T60
mm
SDS-eluted
(60 mm)
AN69
Cuprophan
Polysulfone
634 900 8730
725 300 8420
466 000 18270
26 580 1050
14 150 500
65 000 1130
Discussion
The present study demonstrates that intact LPS contaminat-
ing the dialysate may cross AN69, polysulfone and cuprophan
membranes. These results provide a basis for the chronic
stimulation of IL-I production by circulating monocytes of
patients undergoing hemodialysis with high permeability mem-
branes and an additional mechanism by which complement
induced stimulation of IL-I production may be potentiated in
patients dialysed with cellulose membranes.
We used non-enterobacterial LPS to contaminate dialysates
of in vitro dialysis circuits. The dialyzers were either standard
dialyzers for clinical use or miniaturized dialyzers. LPSs were
LPS from Nm, a potent IL-i inducer [20] and LPS purified from
Pt, a bacterial strain grown out from clinically used dialysates.
Pseudomonas represent the bacterial species that is the most
frequently isolated from contaminated bicarbonate dialysates.
Preparations of purified LPSs did not contain protein nor DNA.
Contamination of the dialysate with Nm LPS resulted in a peak
of IL-I inducing activity occurring within the first twenty
minutes of dialysis, as assessed by the ability of samples taken
from the blood compartment to induce cell-associated IL-I
activity in cultures of normal human monocytes. We have no
explanation at this time for the transient character of the
appearance of IL-i inducing activity in the blood compartment,
which we have consistently observed. A transient peak of IL-I
inducing activity in the blood compartment was also observed
following artificially-induced back filtration in the circuit. No
IL-i inducing activity was found in the blood compartment
when the dialysate had not been contaminated with LPS. These
observations extend to high permeability membranes the earlier
results, indicating that IL-I inducing activity in the blood
compartment of in vitro dialysis circuits having cellulose mem-
branes is associated with contamination of dialysate with endo-
toxin [2, 3]. One of the latter studies indicated a requirement for
plasma in the blood compartment in order to detect an IL-I
inducing activity. These findings may now be interpreted as
reflecting the potentiating effect of plasma proteins on IL-I
induction by suboptimal amounts of LPS [21].
Transmembrane passage of intact LPS through AN69,
polysulfone and cuprophan membranes was demonstrated us-
ing radiolabeled purified Nm LPS and Pt LPS. The labeling
procedure resulted in specific labeling of the carbohydrate
residues of LPS. All radioactivity in the material used to
contaminate dialysates was associated with the LPS molecules.
The kinetics of transmembrane passage of radiolabeled Nm and
Pt LPS were rapid with a maximum of counts observed in the
blood compartment after five to 15 minutes of dialysis. The total
amount of counts recovered in the blood compartment at the
end of dialysis represented 0.1 to 8% of the radioactive input.
Between 5 and 70% of the radioactive LPS absorbed onto
membranes, depending on the nature of the membrane and the
concentration of LPS in the dialysate. Polysulfone exhibited the
highest capacity to bind endotoxin, as recently described by
Bommer et al [22]. Approximately 5% of LPS from the dialysate
adsorbed onto cuprophan. The amount of LPS adsorbed onto
membranes decreased with the concentration of LPS in the
dialysate compartment. The material that had crossed mem-
branes had a molecular weight similar to the original LPS used
to contaminate the dialysate indicating that it was intact LPS.
Previous attempts using the LAL assay, had failed to dem-
onstrate the transmembrane passage of endotoxin through
cuprophan and polysulfone membranes [8—li]. The LAL assay
only detects species of LPS with an apparent Mr above 8,000
Da [23]. The ability of LPS to react with limulus lymph does not
correlate with its capacity to induce IL-I production [23]. We
have recently shown that IL-I may be induced in cultures of
human monocytes by low molecular weight LAL-unreactive
species of LPS [23]. Thus, the lack of detectable LAL-reactive
material in the blood compartment does not rule out transmem-
brane passage of LAL-unreactive IL-I inducing species of LPS.
The culture of normal monocytes in the presence of LPS for
five hours is sufficient to trigger cell production of IL-i for 96
hours [21, N. Haeffner-Cavaillon, unpublished observations].
The contact of circulating monocytes with LPS in the blood
compartment during hemodialysis in vivo should therefore be
sufficient to stimulate the cells to produce IL-I for several days.
These observations may explain our previous findings of high
x
E
U)
-J
I
10
T
5-
0-
—
-
.
/1:-
0 5 15 30 60
Time, minutes
Fig. 7. Kinetics of transmembrane passage of 'H Pt LPS through
AN69 (O----O), polysulfone (• •) and cuprophan (A----A)mem-
branes. Closed dialysis circuits. Filtral 12 (AN69), Hemoflow F60
(polysulfone) and NT 1108 (cuprophan) dialyzers. The curves depict the
radioactivity detected in the blood compartment. The figure shows a
representative experiment out of three that were performed. Each point
represents the mean of triplicate measurements (SD between tnplicates
did not exceed 10% of the mean).
a In vitro closed dialysis circuit. Pyrogen-free saline was circulated in
the blood compartment. Bicarbonate was circulated in the dialysate
compartment. No back filtration. 760,000 cpm of 13H] Nm LPS were
added to the dialysate at To.
b Data are means SD of cpm in triplicate samples
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levels of cell associated IL-I 72 hours after dialysis with AN69
membranes [1].
Transmembrane passage of intact LPS through cuprophan
membranes may result in the potentiation of C3alC3adesArg
and C5alC5adesArg-dependent induction of IL-i by monocytes
[24—26]. Contamination of dialysates with LPS may thus en-
hance the risk for IL-i-mediated adverse effects during hemo-
dialysis with complement-activating cellulose membranes.
The finding of transmembrane passage of low molecular
weight intact species of LPS that are found in clinically used
dialysates emphasizes the importance of obtaining LPS-free
dialysates in order to improve the biocompatibility of hemodi-
alysis.
Acknowledgments
This work was supported by Institut National de Ia sante et de Ia
recherche Médicale (INSERM), Commission de Ia Recherche Clinique
des Hopitaux dc Paris, Hospal S.A. and the Groupement d'Interêt
Public "Therapeutiques Substitutives", France. M. Laude-Sharp is a
recipient of grant from Hospal. LPS from Neisseria memingitidis was a
gift from Dr. D. Schultz, Institut Merieux, Lyon, France. The contri-
bution of T. Crost and F. Lantreibecq to this work is gratefully
acknowledged. The authors have appreciated helpful discussion with C.
Collier and M.J. Transy (Hospal, COT). The authors also thank A.
Vioux for secretarial assistance.
Reprint requests to Nicole Haeffner-Cavaillon, INSERM U28, Hop-
ital Broussais, 96 rue Didot, 75014 Paris, France.
References
I. HAEEFNER-CAVAILLON N, CAVAILLON JM, CIANcI0NI C, BACLE
F, DELONS S, KAZATCHKINE MD: In vivo induction of interleu-
kin-i during hemodialysis. Kidney In: 35:1212—1218, 1989
2. DINARELLO CA, KOCH KM, SHALDON S: Interleukin-I and its
relevance in patients treated with hemodialysis. Kidney In: 33:521-
526, 1988
3. SHALDON S, DINARELLO CA: The relationship between biocom-
patibility and interleukin-I. Life Support Systems 5:341—345, 1987
4. KAZATCHKINE MD, CARRENO MP: Activation of the complement
system at the interface between blood and artificial surfaces.
Biomaterials 9:30—35, 1988
5. CHENOwETH DE, CHEUNG AK, WARD DM, HENDERSON LW:
Anaphylatoxin formation during hemodialysis: Effects of different
dialyzer membranes. Kidney In: 24:764—769, 1983
6. HAKIM RM, BREILLA HJ, LAZARUS JM, PORT FK: Complement
activation and hypersensitivity reactions to dialysis membranes. N
EnglJ Med 311:878—882, i984
7. BINGEL M, LONNEMANN G, SHALDON S. KOCH KM, DINARELLO
CA: Human interleukin-i production during hemodialysis. Neph-
ron 43: 161—163, 1986
8. LONNEMANN G, BINGEL M, FLOEGE J, KOCH KM, SHALDON S,
DINARELLO CA: Detection of endotoxin-like interleukin-l-inducing
activity during in vitro dialysis. Kidney mt 33:29—35, 1988
9. BERNICE JJ, PORT FK, FAVERO MS: In vivo studies of dialysis-
related endotoxemia and bacteremia. Nephron 27:307—319, 1981
10. PORT FK, BERNICK JJ: Pyrogen and endotoxin reactions during
hemodialysis. Con:rib Nephrol 36:100—106, 1983
II. BOMMER J, BECKER KP, URBASCHECK R, URBASCHECK B: Sind
polysurfonmenbranen Pyrogen-permeable? Nieren-und Hoch-
druck-krankhei:en 9:411—412, 1985
12. GALANOS C, LUDERITZ 0, WESTPHAL0: A new method for the
extraction of R lipopolysaccharide. EurJ Biochem 9:245—249, 1969
13. FRESNEAU C, BLANOT D, HILL M, DUPAIX A, BARRIO D: Demon-
stration of the peptide nature of luciferin from purocytis limula. In:
JRes 31:126—129, 1988
14. TSAI CM, FRASCH E: A sensitive silver strain for detecting lipo-
polysaccharides in polyacrylamide gels. Anal Biol 119:115—119,
1982
IS. WATSON J, RIBLET R: Genetic control of responses to bacterial
lipopolysaccharides in mice. A gene that influences a membrane
component involved in the activation of bone-marrow-derived
lymphocytes by lipopolysaccharides. J Immunol 114:1462—1466,
1975
16. HAEFFNER-CAVAILLON N, CHABY R, CAVAILLON JM, SZABO L:
Lipopolysaccharide receptor on rabbit peritoneal macrophages. I.
Binding characteristics. J Immunol 128:1950—1954, 1982
17. TICKER SB, PIERRE RV, JORDON RE: Rapid identification of
monocytes in a mixed mononuclear cell preparation. J Immunol
Meth 14:267—269, 1977
18. LEPE-ZUNIGA JL, ZIGLER JS, ZIMMERMAN ML, Guy I: Differ-
ences between intra and extracellular interleukin- I. Mo! Immunol
22:1387—1392, 1985
19. HAEFFNER-CAVAILLON N, CAVAILLON JM, MOREAU M, SZABO L:
interleukin-l secretion by human monocytes stimulated by the
isolated polysaccharide region of Bordetella pertussis endotoxin.
Mo! Immunol 21:389—395, 1984
20. HAEFFNER-CAVAILLON N, BACLE F, CAROFF M, CAVAILLON JM:
Characteristics of lipopolysaccharide-induced interleukin- I produc-
tion by human monocytes. Clinical relevance in patients undergo-
ing hemodialysis. Progr Clin Biol Res 272:89-101, 1988
21. CAVAILLON JM, HAEFFNER-CAVAILLON N: The role of serum in
interleukin- I production by human monocytes activated by endo-
toxin and their polysaccharide moieties. Immuno! Let: 10:35—41,
1985
22. BOMMER J, BECKER KP, URBASCHEK R, RITZ E, URBASCHEK B:
No evidence for endotoxin transfer across high flu-polysulfone
membranes. Clin Nephrol 27:278—282, 1987
23. LAUDE-SHARP M, HAEFFNER-CAVAILLON N, CAROFF M,
LANTREIBECQ F, PUSINERI C, KAZATCHKINE M: Dissociation
between the interleukin-l-inducing capacity and limulus reactivity
of Iipopolysaccharides from gram-negative bacteria. (submitted for
publication)
24. HAEFFNER-CAVAILLON N, CAVAILLON JM, LAUDE M, KAZATCH-
KINE M: C3a (C3adesArg) induces production and release of
interleukin-l by cultured human monocytes. J Immunol 139:794—
799, 1987
25. OKUSAWA S, DINARELLO CA, YANCEY KB, ENDER5 S, LAWLEY
Ti, FRANCK MM, BURKE JF, GELFRAND JA: C5a induction of
human interleukin- I synergistic effect with endotoxin or interferon
r. J Immunol 139:2635—2640, 1987
26. CAVAILLON JM, FImNO C, HAEFFNER-CAVAILLON N: Recombi-
nant C5a enhances interleukin- I and tumor necrosis factor release
by lipopolysaccharides stimulated monocytes and macrophages.
Eur J Immunol 20:253—257, 1990
